Hong Kong-listed cardiovascular medical devices developer Venus Medtech, Asia-focused private equity firm DCP Capital, and Chinese venture capital firm Qiming Venture Partners have inked an agreement to launch a healthcare investment platform.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
